An-chi Lin

Taoyuan, TNQ 33305, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Corrigendum to "Androgen receptor may promote tumor progression via TTF-1/EGFR pathway in metastatic nasopharyngeal carcinoma" [Translational Oncology, Volume 65, March 2026, 102670].

Corrigendum to "Androgen receptor may promote tumor progression via TTF-1/EGFR pathway in metastatic nasopharyngeal carcinoma" [Translational Oncology, Volume 65, March 2026, 102670].

Journal: Translational oncology

Published: April 18, 2026

SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma.

SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma.

Journal: American journal of cancer research

Published: December 25, 2025

Androgen receptor may promote tumor progression via TTF-1/EGFR pathway in metastatic nasopharyngeal carcinoma.

Androgen receptor may promote tumor progression via TTF-1/EGFR pathway in metastatic nasopharyngeal carcinoma.

Journal: Translational oncology

Published: August 23, 2025

Characterization of the immune cell profile in metastatic nasopharyngeal carcinoma treated with chemotherapy and immune checkpoint inhibitors.

Characterization of the immune cell profile in metastatic nasopharyngeal carcinoma treated with chemotherapy and immune checkpoint inhibitors.

Journal: American journal of cancer research

Published: October 29, 2024

A patient-derived xenograft mouse platform from epithelioid glioblastoma provides possible druggable screening and translational study.

A patient-derived xenograft mouse platform from epithelioid glioblastoma provides possible druggable screening and translational study.

Journal: American journal of cancer research

Published: May 01, 2024

Paraneoplastic leukocytosis induces NETosis and thrombosis in bladder cancer PDX model.

Paraneoplastic leukocytosis induces NETosis and thrombosis in bladder cancer PDX model.

Journal: American journal of cancer research

Published: February 11, 2024

Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways.

Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways.

Journal: Translational oncology

Published: July 05, 2023

Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment.

Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment.

Journal: Cancers

Published: May 10, 2021

Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening.

Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening.

Journal: Oncotarget

Published: November 04, 2016

Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis.

Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis.

Journal: Molecular oncology

Published: February 24, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026